Cervical Cancer Screening Strategies
A Retrospective Cohort Study on the Effectiveness of Various Screening Strategies for Uterine Cervical Cancer
This study is to investigate retrospectively the results of cervical cytology and high-risk human papillomavirus in the past 20 years recorded in Peking Union Medical College Hospital. The histological findings after cervical cancer screening were reviewed. The diagnostic values of different screening strategies were compared based on the results of cervical histology. The primary endpoint is the diagnosis of grade 2 cervical intraepithelial neoplasia (CIN2) or more severe lesions (CIN2+). The secondary endpoints include following objectives: (1) the invasive procedures needed according to the screening results; (2) the diagnosis of vaginal and/or vulval intraepithelial neoplasia; (3) the persistence and recurrence of human papillomavirus infection; and (4) the cost-effectiveness of screening strategies for CIN2+.
* Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.
March 19, 2022
March 19, 2025
Primary Completion Date
March 19, 2024
Inclusion Criteria: - Aged 18 years or older - With definite cervical histology after cervical cancer screening, ore with at least one screening test after first testing Exclusion Criteria: - Not meeting all of the inclusion criteria
18 Years - N/A
Accepts Healthy Volunteers
Lei Li, M.D., 86-139-1198-8831, [email protected]
Lei Li, M.D., Principal Investigator, Peking Union Medical College Hospital